Monica Singh
About Monica Singh
Monica Singh is a Senior Manager of Drug Safety at Nektar Therapeutics, with extensive experience in pharmacovigilance and drug safety across various pharmaceutical companies. She holds a B.Pharm and a Master's degree in Regulatory Affairs, and has worked in roles at notable organizations such as Otsuka Pharmaceutical and Janssen Pharmaceuticals.
Current Role at Nektar Therapeutics
Monica Singh serves as the Senior Manager of Drug Safety at Nektar Therapeutics. She has held this position since 2021, contributing to the company's commitment to ensuring the safety and efficacy of its pharmaceutical products. In her role, she oversees drug safety operations and implements pharmacovigilance strategies to monitor and evaluate the safety profiles of drugs.
Previous Experience in Pharmacovigilance
Prior to her current role, Monica Singh gained extensive experience in pharmacovigilance across various organizations. She worked as a Pharmacovigilance Scientist at The Janssen Pharmaceutical Companies of Johnson & Johnson for three months in 2021. Additionally, she held positions at Wipro as a Pharmacovigilance Officer, APCER PHARMA as a Senior Pharmacovigilance Associate, and Alkermes as a Pharmacovigilance Scientist.
Educational Background in Pharmacology and Clinical Research
Monica Singh completed her Bachelor of Pharmacy (B.Pharm) at KIET Group of Institutions from 2006 to 2010, where she studied pharmacology, medicinal chemistry, and pharmaceutics. She furthered her education by obtaining a Post Graduation Diploma in Advanced Clinical Research (PGDACR) from the Institute of Clinical Research, India, from 2010 to 2011. Additionally, she earned a Master's Degree in Regulatory Affairs in Drugs, Biologics, and Medical Devices from Northeastern University between 2014 and 2016.
Career Progression in the Pharmaceutical Industry
Monica Singh's career in the pharmaceutical industry includes roles at various reputable companies. She worked as a Periodic Report Associate at Sanofi Genzyme from 2015 to 2017 and as a Senior Drug Safety Specialist at Synowledge LLC from 2012 to 2014. Her experience also includes a position as a Drug Safety Research Analyst at Advera Health Analytics in 2015 and as a Medical Scientist at Otsuka Pharmaceutical Companies from 2018 to 2021.